CXCL1 and breast carcinoma: In line with these findings, mechanistic studies conducted on MDA-MB-231 cells and several primary human breast cancers have revealed the miR181b upregulation involved in the curcumin-induced, downregulatory effect on CXCL1 and -2, which mediated its anti-metastatic potential [128].